Cardiogen
Also known as: cardiogen peptide, T-32 (related peptide mentioned in same study), short peptide cardiogen
Short bioregulatory peptide
What it is
Based solely on the single relevant abstract identified, cardiogen is described as a short peptide that, along with related peptides T-32 and T-38, was shown in an in vitro cell aging model to enhance expression of signaling factors of human prostate fibroblast differentiation — specifically CXCL12, WEDC1, and ghrelin — in aging cultures where synthesis of these markers had significantly decreased. The peptide was applied in a co-culture system of prostate epithelial cells and fibroblasts and assessed by confocal laser microscopy. No mechanism of action in cardiac tissue is described in any of the reviewed abstracts. All other abstracts in the provided set do not address the peptide "Cardiogen" and instead concern unrelated topics (cardiac amyloidosis, cardiogenic shock as a clinical syndrome, rubidium-82 PET generator named CardioGen-82, cardiomyopathy registries, etc.).
Class: Short bioregulatory peptide
What it's studied for
- Enhancement of signaling factor expression (CXCL12, WEDC1, ghrelin) in aging human prostate fibroblasts in vitro In vitro only
- Cardiogen (alongside peptides T-32 and T-38) enhanced expression of CXCL12, WEDC1, and ghrelin in aging human prostate fibroblast cultures, with expression levels tending to exceed those of young control cultures (after 1 passage) even in older cultures (after 7 passages), as assessed by confocal laser microscopy. PMID 20586252 Kheifets OV et al. Advances in gerontology = Uspekhi gerontologii. 2010.
Frequently asked
What is Cardiogen and what is it used for?
Cardiogen is described in one identified published study as a short bioregulatory peptide investigated in an in vitro model of human prostate fibroblast aging. That study found it enhanced expression of certain signaling factors (CXCL12, WEDC1, ghrelin) in aging cell cultures. No human clinical studies, cardiac-specific studies, or other uses are documented in the reviewed literature.
What dose of Cardiogen should I take?
I'm not a medical professional and can't recommend a protocol for you specifically. What research has shown: No dosage information for Cardiogen in humans appears in any of the reviewed published abstracts. The only identified study is an in vitro cell culture experiment with no dose stated for human use.
How do I inject Cardiogen?
I'm not a medical professional and can't recommend a protocol for you specifically. What research has shown: No route of administration, injection method, or reconstitution protocol for Cardiogen is described in any of the reviewed published abstracts.
Is Cardiogen approved by the FDA or legal to use?
The reviewed published literature does not address the regulatory status of the peptide Cardiogen under any jurisdiction (FDA, Health Canada, WADA, or other). This requires manual verification with regulatory authorities. Please consult a licensed healthcare provider.
Can I stack Cardiogen with other peptides?
I can't recommend combining compounds — that's a prescribing decision. Here's what has been studied individually: The only identified study on Cardiogen is an in vitro experiment; no human stacking data exist in the reviewed literature.
What are the side effects of Cardiogen?
I don't have reliable study data on that specific question. I won't guess — please consult a licensed provider or peer-reviewed literature directly. No safety, tolerability, or adverse effect data for Cardiogen appear in any of the reviewed published abstracts.
Does Cardiogen help with heart conditions?
Despite its name, no reviewed abstract documents Cardiogen's use for cardiac conditions in humans or animals. The sole identified relevant abstract reports in vitro effects on prostate fibroblast aging markers only. Many other abstracts returned in this search concerned unrelated topics (e.g., cardiogenic shock, cardiac amyloidosis, or a rubidium-82 PET generator also called 'CardioGen-82') that do not describe the peptide Cardiogen.
Where can I buy Cardiogen?
I don't recommend vendors or sources. Please consult a licensed provider.
Is Cardiogen banned in sport?
I don't have reliable study data on that specific question. I won't guess — please consult a licensed provider or peer-reviewed literature directly. No WADA or anti-doping regulatory status for Cardiogen is stated in any of the reviewed published abstracts.
References
- [1] PMID 20586252 — Cardiogen (alongside peptides T-32 and T-38) enhanced expression of CXCL12, WEDC1, and ghrelin in aging human prostate fibroblast cultures, with expression leve